APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microbiota Transplantation Overall Solution

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Microbiota Transplantation Overall Solution Market Outlook and Growth Opportunities 2026

16 April 2026Not stated

Choose your research edition.

Industry ResearchMicrobiota Transplantation Overall Solution Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Microbiota Transplantation Overall Solution Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Microbiota Transplantation Overall Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microbiota Transplantation Overall Solution Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Microbiota Transplantation Overall Solution Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Microbiota Transplantation Overall Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Microbiota Transplantation Overall Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Microbiota Transplantation Overall Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Microbiota Transplantation Overall Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Microbiota Transplantation Overall Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Microbiota Transplantation Overall Solution market include Ferring Pharmaceuticals, Seres Therapeutics, Finch Therapeutics, OpenBiome, Vedanta Biosciences, MaaT Pharma, BiomX, Entera Health and Metabiomics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Microbiota Transplantation Overall Solution market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Microbiota Transplantation Overall Solution and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Microbiota Transplantation Overall Solution revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Microbiota Transplantation Overall Solution market.

Microbiota Transplantation Overall Solution Segment by Company

Ferring Pharmaceuticals

Seres Therapeutics

Finch Therapeutics

OpenBiome

Vedanta Biosciences

MaaT Pharma

BiomX

Entera Health

Metabiomics

J-Pharma

KoBioLabs

Hangzhou Shengshi Technology

Ruiyi Biotechnology

Jiangsu Junkey Life Technology Development

Hangzhou Yuanxiang Medical Technology

MAUSOAR

Shanghai Chengge Biotechnology

Guangzhou Zhiyi Biotechnology

Shenzhen Unknown Jun Biotechnology

Sichuan Anaerobic Biotechnology

Microbiota Transplantation Overall Solution Segment by Type

Fresh Donor Flora Transplantation Protocol

Standard Frozen Flora Transplantation Protocol

Synthetic Flora Preparation Transplantation Protocol

Microbiota Transplantation Overall Solution Segment by Application

Medical and Health Industry

Scientific Research and Education Industry

Others

Microbiota Transplantation Overall Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Microbiota Transplantation Overall Solution status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Microbiota Transplantation Overall Solution key companies, revenue, market share, and recent developments.

3. To split the Microbiota Transplantation Overall Solution breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Microbiota Transplantation Overall Solution market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Microbiota Transplantation Overall Solution significant trends, drivers, influence factors in global and regions.

6. To analyze Microbiota Transplantation Overall Solution competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbiota Transplantation Overall Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microbiota Transplantation Overall Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbiota Transplantation Overall Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Microbiota Transplantation Overall Solution industry.

Chapter 3: Detailed analysis of Microbiota Transplantation Overall Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Microbiota Transplantation Overall Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Microbiota Transplantation Overall Solution in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Microbiota Transplantation Overall Solution Industry Trends Table 2. Microbiota Transplantation Overall Solution Industry Drivers Table 3. Microbiota Transplantation Overall Solution Industry Opportunities and Challenges Table 4. Microbiota Transplantation Overall Solution Industry Restraints Table 5. Global Microbiota Transplantation Overall Solution Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Microbiota Transplantation Overall Solution Revenue Share by Company (2021-2026) Table 7. Global Microbiota Transplantation Overall Solution Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Microbiota Transplantation Overall Solution Key Company Manufacturing Base & Headquarters Table 9. Global Microbiota Transplantation Overall Solution Company, Product Type & Application Table 10. Global Microbiota Transplantation Overall Solution Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Microbiota Transplantation Overall Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Fresh Donor Flora Transplantation Protocol Table 15. Significant Companies of Standard Frozen Flora Transplantation Protocol Table 16. Significant Companies of Synthetic Flora Preparation Transplantation Protocol Table 17. Global Microbiota Transplantation Overall Solution Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Microbiota Transplantation Overall Solution Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Microbiota Transplantation Overall Solution Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Microbiota Transplantation Overall Solution Sales Value Share by Type (2021-2026) Table 21. Global Microbiota Transplantation Overall Solution Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Medical and Health Industry Table 23. Significant Companies of Scientific Research and Education Industry Table 24. Significant Companies of Others Table 25. Global Microbiota Transplantation Overall Solution Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Microbiota Transplantation Overall Solution Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Microbiota Transplantation Overall Solution Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Microbiota Transplantation Overall Solution Sales Value Share by Application (2021-2026) Table 29. Global Microbiota Transplantation Overall Solution Sales Value Share by Application (2027-2032) Table 30. Global Microbiota Transplantation Overall Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Microbiota Transplantation Overall Solution Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Microbiota Transplantation Overall Solution Sales Value Share by Region (2021-2026) Table 33. Global Microbiota Transplantation Overall Solution Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Microbiota Transplantation Overall Solution Sales Value Share by Region (2027-2032) Table 35. Global Microbiota Transplantation Overall Solution Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Microbiota Transplantation Overall Solution Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Microbiota Transplantation Overall Solution Sales Value Market Share by Country (2021-2026) Table 38. Global Microbiota Transplantation Overall Solution Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Microbiota Transplantation Overall Solution Sales Value Market Share by Country (2027-2032) Table 40. Ferring Pharmaceuticals Company Information Table 41. Ferring Pharmaceuticals Business Overview Table 42. Ferring Pharmaceuticals Microbiota Transplantation Overall Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Ferring Pharmaceuticals Microbiota Transplantation Overall Solution Product Portfolio Table 44. Ferring Pharmaceuticals Recent Development Table 45. Seres Therapeutics Company Information Table 46. Seres Therapeutics Business Overview Table 47. Seres Therapeutics Microbiota Transplantation Overall Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Seres Therapeutics Microbiota Transplantation Overall Solution Product Portfolio Table 49. Seres Therapeutics Recent Development Table 50. Finch Therapeutics Company Information Table 51. Finch Therapeutics Business Overview Table 52. Finch Therapeutics Microbiota Transplantation Overall Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Finch Therapeutics Microbiota Transplantation Overall Solution Product Portfolio Table 54. Finch Therapeutics Recent Development Table 55. OpenBiome Company Information Table 56. OpenBiome Business Overview Table 57. OpenBiome Microbiota Transplantation Overall Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. OpenBiome Microbiota Transplantation Overall Solution Product Portfolio Table 59. OpenBiome Recent Development Table 60. Vedanta Biosciences Company Information Table 61. Vedanta Biosciences Business Overview Table 62. Vedanta Biosciences Microbiota Transplantation Overall Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Vedanta Biosciences Microbiota Transplantation Overall Solution Product Portfolio Table 64. Vedanta Biosciences Recent Development Table 65. MaaT Pharma Company Information Table 66. MaaT Pharma Business Overview Table 67. MaaT Pharma Microbiota Transplantation Overall Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. MaaT Pharma Microbiota Transplantation Overall Solution Product Portfolio Table 69. MaaT Pharma Recent Development Table 70. BiomX Company Information Table 71. BiomX Business Overview Table 72. BiomX Microbiota Transplantation Overall Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. BiomX Microbiota Transplantation Overall Solution Product Portfolio Table 74. BiomX Recent Development Table 75. Entera Health Company Information Table 76. Entera Health Business Overview Table 77. Entera Health Microbiota Transplantation Overall Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Entera Health Microbiota Transplantation Overall Solution Product Portfolio Table 79. Entera Health Recent Development Table 80. Metabiomics Company Information Table 81. Metabiomics Business Overview Table 82. Metabiomics Microbiota Transplantation Overall Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Metabiomics Microbiota Transplantation Overall Solution Product Portfolio Table 84. Metabiomics Recent Development Table 85. J-Pharma Company Information Table 86. J-Pharma Business Overview Table 87. J-Pharma Microbiota Transplantation Overall Solution Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. J-Pharma Microbiota Transplantation Overall Solution Product Portfolio Table 89. J-Pharma Recent Development Table 90. KoBioLabs Company Information Table 91. KoBioLabs Business Overview Table 92. KoBioLabs Microbiota Transplantation Overall Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. KoBioLabs Microbiota Transplantation Overall Solution Product Portfolio Table 94. KoBioLabs Recent Development Table 95. Hangzhou Shengshi Technology Company Information Table 96. Hangzhou Shengshi Technology Business Overview Table 97. Hangzhou Shengshi Technology Microbiota Transplantation Overall Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Hangzhou Shengshi Technology Microbiota Transplantation Overall Solution Product Portfolio Table 99. Hangzhou Shengshi Technology Recent Development Table 100. Ruiyi Biotechnology Company Information Table 101. Ruiyi Biotechnology Business Overview Table 102. Ruiyi Biotechnology Microbiota Transplantation Overall Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Ruiyi Biotechnology Microbiota Transplantation Overall Solution Product Portfolio Table 104. Ruiyi Biotechnology Recent Development Table 105. Jiangsu Junkey Life Technology Development Company Information Table 106. Jiangsu Junkey Life Technology Development Business Overview Table 107. Jiangsu Junkey Life Technology Development Microbiota Transplantation Overall Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Jiangsu Junkey Life Technology Development Microbiota Transplantation Overall Solution Product Portfolio Table 109. Jiangsu Junkey Life Technology Development Recent Development Table 110. Hangzhou Yuanxiang Medical Technology Company Information Table 111. Hangzhou Yuanxiang Medical Technology Business Overview Table 112. Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Overall Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Overall Solution Product Portfolio Table 114. Hangzhou Yuanxiang Medical Technology Recent Development Table 115. MAUSOAR Company Information Table 116. MAUSOAR Business Overview Table 117. MAUSOAR Microbiota Transplantation Overall Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. MAUSOAR Microbiota Transplantation Overall Solution Product Portfolio Table 119. MAUSOAR Recent Development Table 120. Shanghai Chengge Biotechnology Company Information Table 121. Shanghai Chengge Biotechnology Business Overview Table 122. Shanghai Chengge Biotechnology Microbiota Transplantation Overall Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Shanghai Chengge Biotechnology Microbiota Transplantation Overall Solution Product Portfolio Table 124. Shanghai Chengge Biotechnology Recent Development Table 125. Guangzhou Zhiyi Biotechnology Company Information Table 126. Guangzhou Zhiyi Biotechnology Business Overview Table 127. Guangzhou Zhiyi Biotechnology Microbiota Transplantation Overall Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Guangzhou Zhiyi Biotechnology Microbiota Transplantation Overall Solution Product Portfolio Table 129. Guangzhou Zhiyi Biotechnology Recent Development Table 130. Shenzhen Unknown Jun Biotechnology Company Information Table 131. Shenzhen Unknown Jun Biotechnology Business Overview Table 132. Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Overall Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Overall Solution Product Portfolio Table 134. Shenzhen Unknown Jun Biotechnology Recent Development Table 135. Sichuan Anaerobic Biotechnology Company Information Table 136. Sichuan Anaerobic Biotechnology Business Overview Table 137. Sichuan Anaerobic Biotechnology Microbiota Transplantation Overall Solution Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Sichuan Anaerobic Biotechnology Microbiota Transplantation Overall Solution Product Portfolio Table 139. Sichuan Anaerobic Biotechnology Recent Development Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Microbiota Transplantation Overall Solution Product Image Figure 2. Global Microbiota Transplantation Overall Solution Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microbiota Transplantation Overall Solution Market Size (2021-2032) & (US$ Million) Figure 4. Global Microbiota Transplantation Overall Solution Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Fresh Donor Flora Transplantation Protocol Image Figure 8. Standard Frozen Flora Transplantation Protocol Image Figure 9. Synthetic Flora Preparation Transplantation Protocol Image Figure 10. Global Microbiota Transplantation Overall Solution Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Microbiota Transplantation Overall Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Microbiota Transplantation Overall Solution Sales Value Share by Type (2021-2032) Figure 13. Medical and Health Industry Image Figure 14. Scientific Research and Education Industry Image Figure 15. Others Image Figure 16. Global Microbiota Transplantation Overall Solution Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Microbiota Transplantation Overall Solution Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Microbiota Transplantation Overall Solution Sales Value Share by Application (2021-2032) Figure 19. Global Microbiota Transplantation Overall Solution Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Microbiota Transplantation Overall Solution Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Microbiota Transplantation Overall Solution Sales Value (2021-2032) & (US$ Million) Figure 22. North America Microbiota Transplantation Overall Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Microbiota Transplantation Overall Solution Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Microbiota Transplantation Overall Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Microbiota Transplantation Overall Solution Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Microbiota Transplantation Overall Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Microbiota Transplantation Overall Solution Sales Value (2021-2032) & (US$ Million) Figure 28. South America Microbiota Transplantation Overall Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Microbiota Transplantation Overall Solution Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Microbiota Transplantation Overall Solution Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Fresh Donor Flora Transplantation Protocol
  • Standard Frozen Flora Transplantation Protocol
  • Synthetic Flora Preparation Transplantation Protocol
Applications
  • Medical and Health Industry
  • Scientific Research and Education Industry
  • Others
Companies covered
  • Ferring Pharmaceuticals
  • Seres Therapeutics
  • Finch Therapeutics
  • OpenBiome
  • Vedanta Biosciences
  • MaaT Pharma
  • BiomX
  • Entera Health
  • Metabiomics
  • J-Pharma
  • KoBioLabs
  • Hangzhou Shengshi Technology
  • Ruiyi Biotechnology
  • Jiangsu Junkey Life Technology Development
  • Hangzhou Yuanxiang Medical Technology
  • MAUSOAR
  • Shanghai Chengge Biotechnology
  • Guangzhou Zhiyi Biotechnology
  • Shenzhen Unknown Jun Biotechnology
  • Sichuan Anaerobic Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Microbiota Transplantation Overall Solution Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Microbiota Transplantation Overall Solution Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Microbiota Transplantation Overall Solution Market Dynamics
  1. 2.1 Microbiota Transplantation Overall Solution Industry Trends
  2. 2.2 Microbiota Transplantation Overall Solution Industry Drivers
  3. 2.3 Microbiota Transplantation Overall Solution Industry Opportunities and Challenges
  4. 2.4 Microbiota Transplantation Overall Solution Industry Restraints
3 Microbiota Transplantation Overall Solution Market by Company
  1. 3.1 Global Microbiota Transplantation Overall Solution Company Revenue Ranking in 2025
  2. 3.2 Global Microbiota Transplantation Overall Solution Revenue by Company (2021-2026)
  3. 3.3 Global Microbiota Transplantation Overall Solution Company Ranking (2024-2026)
  4. 3.4 Global Microbiota Transplantation Overall Solution Company Manufacturing Base and Headquarters
  5. 3.5 Global Microbiota Transplantation Overall Solution Company Product Type and Application
  6. 3.6 Global Microbiota Transplantation Overall Solution Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Microbiota Transplantation Overall Solution Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Microbiota Transplantation Overall Solution Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Microbiota Transplantation Overall Solution Market by Type
  1. 4.1 Microbiota Transplantation Overall Solution Type Introduction
  2. 4.1.1 Fresh Donor Flora Transplantation Protocol
  3. 4.1.2 Standard Frozen Flora Transplantation Protocol
  4. 4.1.3 Synthetic Flora Preparation Transplantation Protocol
  5. 4.2 Global Microbiota Transplantation Overall Solution Sales Value by Type
  6. 4.2.1 Global Microbiota Transplantation Overall Solution Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Microbiota Transplantation Overall Solution Sales Value by Type (2021-2032)
  8. 4.2.3 Global Microbiota Transplantation Overall Solution Sales Value Share by Type (2021-2032)
5 Microbiota Transplantation Overall Solution Market by Application
  1. 5.1 Microbiota Transplantation Overall Solution Application Introduction
  2. 5.1.1 Medical and Health Industry
  3. 5.1.2 Scientific Research and Education Industry
  4. 5.1.3 Others
  5. 5.2 Global Microbiota Transplantation Overall Solution Sales Value by Application
  6. 5.2.1 Global Microbiota Transplantation Overall Solution Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Microbiota Transplantation Overall Solution Sales Value by Application (2021-2032)
  8. 5.2.3 Global Microbiota Transplantation Overall Solution Sales Value Share by Application (2021-2032)
6 Microbiota Transplantation Overall Solution Regional Value Analysis
  1. 6.1 Global Microbiota Transplantation Overall Solution Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Microbiota Transplantation Overall Solution Sales Value by Region (2021-2032)
  3. 6.2.1 Global Microbiota Transplantation Overall Solution Sales Value by Region: 2021-2026
  4. 6.2.2 Global Microbiota Transplantation Overall Solution Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Microbiota Transplantation Overall Solution Sales Value (2021-2032)
  7. 6.3.2 North America Microbiota Transplantation Overall Solution Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Microbiota Transplantation Overall Solution Sales Value (2021-2032)
  10. 6.4.2 Europe Microbiota Transplantation Overall Solution Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Microbiota Transplantation Overall Solution Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Microbiota Transplantation Overall Solution Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Microbiota Transplantation Overall Solution Sales Value (2021-2032)
  16. 6.6.2 South America Microbiota Transplantation Overall Solution Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Microbiota Transplantation Overall Solution Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Microbiota Transplantation Overall Solution Sales Value Share by Country, 2025 VS 2032
7 Microbiota Transplantation Overall Solution Country-level Value Analysis
  1. 7.1 Global Microbiota Transplantation Overall Solution Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Microbiota Transplantation Overall Solution Sales Value by Country (2021-2032)
  3. 7.2.1 Global Microbiota Transplantation Overall Solution Sales Value by Country (2021-2026)
  4. 7.2.2 Global Microbiota Transplantation Overall Solution Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Microbiota Transplantation Overall Solution Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Microbiota Transplantation Overall Solution Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Microbiota Transplantation Overall Solution Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ferring Pharmaceuticals
  2. 8.1.1 Ferring Pharmaceuticals Company Information
  3. 8.1.2 Ferring Pharmaceuticals Business Overview
  4. 8.1.3 Ferring Pharmaceuticals Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Ferring Pharmaceuticals Microbiota Transplantation Overall Solution Product Portfolio
  6. 8.1.5 Ferring Pharmaceuticals Recent Developments
  7. 8.2 Seres Therapeutics
  8. 8.2.1 Seres Therapeutics Company Information
  9. 8.2.2 Seres Therapeutics Business Overview
  10. 8.2.3 Seres Therapeutics Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Seres Therapeutics Microbiota Transplantation Overall Solution Product Portfolio
  12. 8.2.5 Seres Therapeutics Recent Developments
  13. 8.3 Finch Therapeutics
  14. 8.3.1 Finch Therapeutics Company Information
  15. 8.3.2 Finch Therapeutics Business Overview
  16. 8.3.3 Finch Therapeutics Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Finch Therapeutics Microbiota Transplantation Overall Solution Product Portfolio
  18. 8.3.5 Finch Therapeutics Recent Developments
  19. 8.4 OpenBiome
  20. 8.4.1 OpenBiome Company Information
  21. 8.4.2 OpenBiome Business Overview
  22. 8.4.3 OpenBiome Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  23. 8.4.4 OpenBiome Microbiota Transplantation Overall Solution Product Portfolio
  24. 8.4.5 OpenBiome Recent Developments
  25. 8.5 Vedanta Biosciences
  26. 8.5.1 Vedanta Biosciences Company Information
  27. 8.5.2 Vedanta Biosciences Business Overview
  28. 8.5.3 Vedanta Biosciences Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Vedanta Biosciences Microbiota Transplantation Overall Solution Product Portfolio
  30. 8.5.5 Vedanta Biosciences Recent Developments
  31. 8.6 MaaT Pharma
  32. 8.6.1 MaaT Pharma Company Information
  33. 8.6.2 MaaT Pharma Business Overview
  34. 8.6.3 MaaT Pharma Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  35. 8.6.4 MaaT Pharma Microbiota Transplantation Overall Solution Product Portfolio
  36. 8.6.5 MaaT Pharma Recent Developments
  37. 8.7 BiomX
  38. 8.7.1 BiomX Company Information
  39. 8.7.2 BiomX Business Overview
  40. 8.7.3 BiomX Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BiomX Microbiota Transplantation Overall Solution Product Portfolio
  42. 8.7.5 BiomX Recent Developments
  43. 8.8 Entera Health
  44. 8.8.1 Entera Health Company Information
  45. 8.8.2 Entera Health Business Overview
  46. 8.8.3 Entera Health Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Entera Health Microbiota Transplantation Overall Solution Product Portfolio
  48. 8.8.5 Entera Health Recent Developments
  49. 8.9 Metabiomics
  50. 8.9.1 Metabiomics Company Information
  51. 8.9.2 Metabiomics Business Overview
  52. 8.9.3 Metabiomics Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Metabiomics Microbiota Transplantation Overall Solution Product Portfolio
  54. 8.9.5 Metabiomics Recent Developments
  55. 8.10 J-Pharma
  56. 8.10.1 J-Pharma Company Information
  57. 8.10.2 J-Pharma Business Overview
  58. 8.10.3 J-Pharma Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  59. 8.10.4 J-Pharma Microbiota Transplantation Overall Solution Product Portfolio
  60. 8.10.5 J-Pharma Recent Developments
  61. 8.11 KoBioLabs
  62. 8.11.1 KoBioLabs Company Information
  63. 8.11.2 KoBioLabs Business Overview
  64. 8.11.3 KoBioLabs Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  65. 8.11.4 KoBioLabs Microbiota Transplantation Overall Solution Product Portfolio
  66. 8.11.5 KoBioLabs Recent Developments
  67. 8.12 Hangzhou Shengshi Technology
  68. 8.12.1 Hangzhou Shengshi Technology Company Information
  69. 8.12.2 Hangzhou Shengshi Technology Business Overview
  70. 8.12.3 Hangzhou Shengshi Technology Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hangzhou Shengshi Technology Microbiota Transplantation Overall Solution Product Portfolio
  72. 8.12.5 Hangzhou Shengshi Technology Recent Developments
  73. 8.13 Ruiyi Biotechnology
  74. 8.13.1 Ruiyi Biotechnology Company Information
  75. 8.13.2 Ruiyi Biotechnology Business Overview
  76. 8.13.3 Ruiyi Biotechnology Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Ruiyi Biotechnology Microbiota Transplantation Overall Solution Product Portfolio
  78. 8.13.5 Ruiyi Biotechnology Recent Developments
  79. 8.14 Jiangsu Junkey Life Technology Development
  80. 8.14.1 Jiangsu Junkey Life Technology Development Company Information
  81. 8.14.2 Jiangsu Junkey Life Technology Development Business Overview
  82. 8.14.3 Jiangsu Junkey Life Technology Development Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Jiangsu Junkey Life Technology Development Microbiota Transplantation Overall Solution Product Portfolio
  84. 8.14.5 Jiangsu Junkey Life Technology Development Recent Developments
  85. 8.15 Hangzhou Yuanxiang Medical Technology
  86. 8.15.1 Hangzhou Yuanxiang Medical Technology Company Information
  87. 8.15.2 Hangzhou Yuanxiang Medical Technology Business Overview
  88. 8.15.3 Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Hangzhou Yuanxiang Medical Technology Microbiota Transplantation Overall Solution Product Portfolio
  90. 8.15.5 Hangzhou Yuanxiang Medical Technology Recent Developments
  91. 8.16 MAUSOAR
  92. 8.16.1 MAUSOAR Company Information
  93. 8.16.2 MAUSOAR Business Overview
  94. 8.16.3 MAUSOAR Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  95. 8.16.4 MAUSOAR Microbiota Transplantation Overall Solution Product Portfolio
  96. 8.16.5 MAUSOAR Recent Developments
  97. 8.17 Shanghai Chengge Biotechnology
  98. 8.17.1 Shanghai Chengge Biotechnology Company Information
  99. 8.17.2 Shanghai Chengge Biotechnology Business Overview
  100. 8.17.3 Shanghai Chengge Biotechnology Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Shanghai Chengge Biotechnology Microbiota Transplantation Overall Solution Product Portfolio
  102. 8.17.5 Shanghai Chengge Biotechnology Recent Developments
  103. 8.18 Guangzhou Zhiyi Biotechnology
  104. 8.18.1 Guangzhou Zhiyi Biotechnology Company Information
  105. 8.18.2 Guangzhou Zhiyi Biotechnology Business Overview
  106. 8.18.3 Guangzhou Zhiyi Biotechnology Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Guangzhou Zhiyi Biotechnology Microbiota Transplantation Overall Solution Product Portfolio
  108. 8.18.5 Guangzhou Zhiyi Biotechnology Recent Developments
  109. 8.19 Shenzhen Unknown Jun Biotechnology
  110. 8.19.1 Shenzhen Unknown Jun Biotechnology Company Information
  111. 8.19.2 Shenzhen Unknown Jun Biotechnology Business Overview
  112. 8.19.3 Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Shenzhen Unknown Jun Biotechnology Microbiota Transplantation Overall Solution Product Portfolio
  114. 8.19.5 Shenzhen Unknown Jun Biotechnology Recent Developments
  115. 8.20 Sichuan Anaerobic Biotechnology
  116. 8.20.1 Sichuan Anaerobic Biotechnology Company Information
  117. 8.20.2 Sichuan Anaerobic Biotechnology Business Overview
  118. 8.20.3 Sichuan Anaerobic Biotechnology Microbiota Transplantation Overall Solution Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Sichuan Anaerobic Biotechnology Microbiota Transplantation Overall Solution Product Portfolio
  120. 8.20.5 Sichuan Anaerobic Biotechnology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst